Cardiff Oncology, Inc. — Form 8-K
Filed October 22, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Cardiff Oncology submitted an 8-K on October 22, 2026 disclosing Item 5.07 (Submission of Matters to a Vote of Security Holders). The filing header and XBRL exhibits are present, but the actual text content describing what matters were submitted to vote, vote results, or shareholder actions is not provided in the filing excerpt. Specific dollar amounts, vote counts, or substantive details cannot be determined from this document extract.
Why this rating
Routine 8-K filing of shareholder voting disclosure; no material transaction, financial impact, or strategic detail disclosed in available text.
Extracted items
See more from October 22, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.